Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Beijing Liven Technology (001259.SZ): The actual controlling shareholder intends to transfer 10% of the company's shares through an agreement.
AI enthusiasts have entered a dangerous stage! "Big Short" Berry once again urges investors to reduce their positions in technology stocks.
US Stock Market Move | Nokia Oyj Sponsored ADR (NOK.US) rose by 5% and will sell its FWA CPE business for $20 million.
Beijing Liven Technology (001259.SZ): The actual controlling shareholder intends to transfer 10% of the company's shares through an agreement.
AI enthusiasts have entered a dangerous stage! "Big Short" Berry once again urges investors to reduce their positions in technology stocks.
US Stock Market Move | Nokia Oyj Sponsored ADR (NOK.US) rose by 5% and will sell its FWA CPE business for $20 million.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
